This pre-post study evaluated the impact of smart pump infusion devices on reported adverse drug events (ADEs) in an inpatient setting. Researchers observed an increase in ADEs immediately following implementation of the new devices, as has been previously seen after electronic health record implementation. Subsequently, ADEs returned to rates similar to before smart pump use. This lack of benefit from smart pumps indicates the need for human factors approaches to characterize the actual use of devices.